rs8190996

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000637.5(GSR):​c.696-10C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.449 in 1,572,768 control chromosomes in the GnomAD database, including 160,222 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.42 ( 13723 hom., cov: 32)
Exomes 𝑓: 0.45 ( 146499 hom. )

Consequence

GSR
NM_000637.5 intron

Scores

2
Splicing: ADA: 0.00001487
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.367

Publications

27 publications found
Variant links:
Genes affected
GSR (HGNC:4623): (glutathione-disulfide reductase) This gene encodes a member of the class-I pyridine nucleotide-disulfide oxidoreductase family. This enzyme is a homodimeric flavoprotein. It is a central enzyme of cellular antioxidant defense, and reduces oxidized glutathione disulfide (GSSG) to the sulfhydryl form GSH, which is an important cellular antioxidant. Rare mutations in this gene result in hereditary glutathione reductase deficiency. Multiple alternatively spliced transcript variants encoding different isoforms have been found. [provided by RefSeq, Aug 2010]
GSR Gene-Disease associations (from GenCC):
  • hemolytic anemia due to glutathione reductase deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 8-30696489-G-A is Benign according to our data. Variant chr8-30696489-G-A is described in ClinVar as Benign. ClinVar VariationId is 439766.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.458 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GSRNM_000637.5 linkc.696-10C>T intron_variant Intron 6 of 12 ENST00000221130.11 NP_000628.2 P00390-1V9HW90

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GSRENST00000221130.11 linkc.696-10C>T intron_variant Intron 6 of 12 1 NM_000637.5 ENSP00000221130.5 P00390-1

Frequencies

GnomAD3 genomes
AF:
0.417
AC:
63293
AN:
151804
Hom.:
13717
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.307
Gnomad AMI
AF:
0.352
Gnomad AMR
AF:
0.440
Gnomad ASJ
AF:
0.360
Gnomad EAS
AF:
0.474
Gnomad SAS
AF:
0.450
Gnomad FIN
AF:
0.584
Gnomad MID
AF:
0.404
Gnomad NFE
AF:
0.450
Gnomad OTH
AF:
0.422
GnomAD2 exomes
AF:
0.452
AC:
113277
AN:
250774
AF XY:
0.454
show subpopulations
Gnomad AFR exome
AF:
0.303
Gnomad AMR exome
AF:
0.467
Gnomad ASJ exome
AF:
0.362
Gnomad EAS exome
AF:
0.477
Gnomad FIN exome
AF:
0.575
Gnomad NFE exome
AF:
0.447
Gnomad OTH exome
AF:
0.444
GnomAD4 exome
AF:
0.452
AC:
642387
AN:
1420846
Hom.:
146499
Cov.:
26
AF XY:
0.452
AC XY:
320695
AN XY:
709648
show subpopulations
African (AFR)
AF:
0.294
AC:
9594
AN:
32590
American (AMR)
AF:
0.467
AC:
20851
AN:
44666
Ashkenazi Jewish (ASJ)
AF:
0.366
AC:
9479
AN:
25886
East Asian (EAS)
AF:
0.448
AC:
17688
AN:
39488
South Asian (SAS)
AF:
0.457
AC:
39022
AN:
85426
European-Finnish (FIN)
AF:
0.569
AC:
30365
AN:
53368
Middle Eastern (MID)
AF:
0.368
AC:
2097
AN:
5698
European-Non Finnish (NFE)
AF:
0.453
AC:
487049
AN:
1074616
Other (OTH)
AF:
0.444
AC:
26242
AN:
59108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
16311
32622
48934
65245
81556
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14570
29140
43710
58280
72850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.417
AC:
63324
AN:
151922
Hom.:
13723
Cov.:
32
AF XY:
0.421
AC XY:
31279
AN XY:
74238
show subpopulations
African (AFR)
AF:
0.307
AC:
12721
AN:
41418
American (AMR)
AF:
0.439
AC:
6690
AN:
15230
Ashkenazi Jewish (ASJ)
AF:
0.360
AC:
1249
AN:
3468
East Asian (EAS)
AF:
0.474
AC:
2447
AN:
5162
South Asian (SAS)
AF:
0.449
AC:
2166
AN:
4824
European-Finnish (FIN)
AF:
0.584
AC:
6159
AN:
10554
Middle Eastern (MID)
AF:
0.404
AC:
118
AN:
292
European-Non Finnish (NFE)
AF:
0.450
AC:
30560
AN:
67956
Other (OTH)
AF:
0.424
AC:
893
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1842
3685
5527
7370
9212
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
610
1220
1830
2440
3050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.428
Hom.:
45785
Bravo
AF:
0.402
Asia WGS
AF:
0.463
AC:
1610
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hemolytic anemia due to glutathione reductase deficiency Benign:2
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 26, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

GSR-related disorder Benign:1
Mar 06, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.67
DANN
Benign
0.56
PhyloP100
-0.37
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000015
dbscSNV1_RF
Benign
0.0040
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8190996; hg19: chr8-30554006; COSMIC: COSV55319516; API